Delhi, the national capital of India, experienced multiple severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) outbreaks in 2020 and reached population seropositivity of >50…

Background From an isolated epidemic, coronavirus disease 2019 has now emerged as a
global pandemic. The availability of genomes in the public domain after the epidemic …

Data science has been an invaluable part of the COVID-19 pandemic response with
multiple applications, ranging from tracking viral evolution to understanding the vaccine …

Background Primary SARS-CoV-2 vaccination has been shown to wane with time and provide
lower protection from disease with new viral variants, prompting the WHO to recommend …

To understand the spread of SARS-CoV2, in August and September 2020, the Council of
Scientific and Industrial Research (India) conducted a serosurvey across its constituent …

Background Multiple variants of the SARS-CoV-2 virus have plagued the world through
successive waves of infection over the past three years. Independent research groups across …

Methods This is a single‐center prospective observational cohort study, approved by the
Institutional Ethics Committee of AIG Hospitals. A total of 285 high‐risk, RT‐PCR‐positive SARS…

To understand the transmission characteristics of severe acute respiratory syndrome corona
virus-2 (SARS-CoV-2) through air, samples from different locations occupied by coronavirus …

1. Boyd S, Martin-Loeches I. Rates of aspergillus co-infection in COVID patients in ICU not
as high as previously reported. Clin Infect Dis 2021; 73: e1236–8. 2. Koehler P, Bassetti M, …

Rigorous testing is the way forward to fight the coronavirus disease 2019 pandemic. Here
we show that the currently used and most reliable reverse transcription-polymerase chain …